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Pick Bodies
The smooth, spherical shape of Pick bodies differs from
Alzheimer disease neurofibrillary tangles. Uematsu et al
(Am J Pathol 2012, 180:1394–1397) immunofluores-
cently labeled tau-positive Pick bodies with quantum dot
(QD) nanocrystals for 3D reconstruction via electron mi-
croscopy (EM) to identify QD immunolabeling on the
same Pick body for comparison in detail. The identity of
the QD nanocrystals, which are detectable both by fluo-
rescence light microscopy and by EM, was confirmed via
super-resolution scanning transmission EM. The exact
comparison of the same structure by EM and 3D light
microscopy demonstrated relevance between ultrastruc-
tural details and surrounding structures on a 3D basis.
This method provides further insights into how molecules
woven into specific pathological ultrastructures are at
work in situ.
Full-Genome Dissection of an Epidemic
Group A Streptococcus
An epidemic of severe invasive human infections caused by
type emm59 group A Streptococcus (GAS) spread across
Canada from 2006 to 2008. By sequencing the genomes of
601 epidemic, historic, and other emm59 organisms, Fitti-
paldi et al (Am J Pathol 2012, 180:1522–1534) identified a
recently emerged, genetically distinct emm59 clone as be-
ing responsible for this epidemic, as well as its spread into
the United States. Mouse and nonhuman primate models
demonstrated that the emerged clone is unusually virulent,
with transmission occurring primarily by skin contact. In
addition, the emm59 strains had a significantly impaired
ability to persist in human saliva, colonized the oropharynx
of mice, and seldom caused human pharyngitis. This anal-
ysis illustrates how full-genome data can be used to pre-
cisely illuminate the landscape of strain dissemination dur-
ing a bacterial epidemic.
FTY720 Aids Recovery after Spinal Cord Injury
Levels of the lysophospholipid mediator sphingosine-1-
phosphate (S1P) increase in the spinal cord after contu-
sion injury. To apply S1P receptor modulation to the treat-
ment of spinal cord injury (SCI), Norimatsu et al (Am J
Pathol 2012, 180:1625–1635) examined the therapeutic
effects of FTY720, an S1P receptor agonist, on locomotor
recovery after SCI in mice. FTY720 administered orally
shortly after contusion SCI significantly improved motor
function recovery, induced lymphopenia, and reducedT-cell infiltration in the spinal cord, but it did not affect
early neutrophil infiltration, microglial activation, or ex-
pression of inflammatory cytokines. Vascular permeabil-
ity and astrocyte accumulation were both decreased by
FTY720 in the injured spinal cord. FTY720 also amelio-
rated motor function after SCI in mice with severe com-
bined immunodeficiency. These data highlight the impor-
tance of immune-independent functions of FTY720 in
promoting locomotor function recovery after SCI.
APP Is a Biomarker for Transformed
Stem Cells
An important function of the -amyloid precursor protein
(APP) may exist in malignant disease, but its biological
basis is unclear. To understand the role of APP in trans-
formed pluripotent stem cells, Venkataraman et al (Am J
Pathol 2012, 180:1636–1652) studied its expression lev-
els in human testicular germ cell tumors. The cooperative
expression of APP aligned with prominent pluripotency-
related genes (Sox2, NANOG, and Oct3/4); however, the
closest homologue family member, APLP2, showed no
correlation. In addition, treatment with histone deacety-
lase (HDAC) inhibitors suppressed the levels of APP and
stem cell markers. Loss of pluripotency was accompa-
nied by decreased APP protein levels both in vitro and
in vivo. Thus, APP represents a novel and specific bio-
marker in human transformed pluripotent stem cells that
can be selectively modulated by HDAC inhibitors.
EPO Protects Neuroretinal Function in
Ischemic Retinopathy
Retinal ischemia is a common feature of vision loss caused
by diabetes, retinal vascular occlusion, and retinopathy of
prematurity. Mowat et al (Am J Pathol 2012, 180:1726–
1739) investigated the effects of ischemia inmurine oxygen-
induced retinopathy (OIR) on retinal function and neurode-
generation. OIR was associated with significant neuroretinal
dysfunction as well as significantly increased apoptosis and
atrophy of the inner retina. Erythropoietin (EPO) deficiency
in heterozygous Epo-Tag transgenic mice led to more pro-
found retinal dysfunction after OIR but had no measurable
effect on the extent of retinal ischemia, preretinal neovas-
cularization, or neuroretinal degeneration. Systemic admin-
istration of recombinant EPO protected EPO-deficient mice,
but EPO supplementation in wild-type animals with OIR did
not rescue neuroretinal dysfunction or degeneration. There-
fore, endogenous EPO can protect neuroretinal function in
ischemic retinopathy.
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